Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Wikstrand

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Cancer Research|December 1, 1977
Surface antigenic characteristics of human glial brain tumor cellsC J Wikstrand, M S Mahaley, D D Bigner
Journal of Neuroimmunology|December 1, 1986
Glioma-associated antigens defined by monoclonal antibodies against an avian sarcoma virus-induced rat astrocytomaY S Lee, C J Wikstrand, D D Bigner
Seminars in Oncology|April 1, 1994
Immunobiology of malignant astrocytomasS N Kurpad, C J Wikstrand, D D Bigner
Endocrine-Related Cancer|June 9, 2001
EGF mutant receptor vIII as a molecular target in cancer therapyC T Kuan, C J Wikstrand, D D Bigner
Brain Tumor Pathology|February 24, 2001
EGFRvIII as a promising target for antibody-based brain tumor therapyC T Kuan, C J Wikstrand, D D Bigner
Invasion & Metastasis|January 1, 1991
Medulloblastoma cell-substrate interaction in vitroC J Wikstrand, H S Friedman, D D Bigner
Cancer Research|July 1, 1983
Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodiesC J Wikstrand, S H Bigner, D D Bigner
Journal of Neuroimmunology|June 1, 1984
Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MGC J Wikstrand, S H Bigner, D D Bigner
Annals of the New York Academy of Sciences|January 1, 1988
Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodiesF D Vrionis, C J Wikstrand, D D Bigner
Progress in Brain Research|January 1, 1994
Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodiesC J Wikstrand, P Fredman, L Svennerholm, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Cancer Research|December 1, 1977
Surface antigenic characteristics of human glial brain tumor cellsC J Wikstrand, M S Mahaley, D D Bigner
Journal of Neuroimmunology|December 1, 1986
Glioma-associated antigens defined by monoclonal antibodies against an avian sarcoma virus-induced rat astrocytomaY S Lee, C J Wikstrand, D D Bigner
Seminars in Oncology|April 1, 1994
Immunobiology of malignant astrocytomasS N Kurpad, C J Wikstrand, D D Bigner
Endocrine-Related Cancer|June 9, 2001
EGF mutant receptor vIII as a molecular target in cancer therapyC T Kuan, C J Wikstrand, D D Bigner
Brain Tumor Pathology|February 24, 2001
EGFRvIII as a promising target for antibody-based brain tumor therapyC T Kuan, C J Wikstrand, D D Bigner
Invasion & Metastasis|January 1, 1991
Medulloblastoma cell-substrate interaction in vitroC J Wikstrand, H S Friedman, D D Bigner
Cancer Research|July 1, 1983
Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodiesC J Wikstrand, S H Bigner, D D Bigner
Journal of Neuroimmunology|June 1, 1984
Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MGC J Wikstrand, S H Bigner, D D Bigner
Annals of the New York Academy of Sciences|January 1, 1988
Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodiesF D Vrionis, C J Wikstrand, D D Bigner
Progress in Brain Research|January 1, 1994
Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodiesC J Wikstrand, P Fredman, L Svennerholm, et al.
Pageof 9